1. Home
  2. IVVD vs CBAT Comparison

IVVD vs CBAT Comparison

Compare IVVD & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
    SELLHOLDBUYas of 2 hours ago
  • CBAT
    SELLHOLDBUYas of 2 hours ago
  • Stock Information
  • Founded
  • IVVD 2020
  • CBAT 1999
  • Country
  • IVVD United States
  • CBAT China
  • Employees
  • IVVD N/A
  • CBAT N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • CBAT Industrial Machinery/Components
  • Sector
  • IVVD Health Care
  • CBAT Miscellaneous
  • Exchange
  • IVVD Nasdaq
  • CBAT Nasdaq
  • Market Cap
  • IVVD 66.6M
  • CBAT 83.0M
  • IPO Year
  • IVVD 2021
  • CBAT N/A
  • Fundamental
  • Price
  • IVVD $1.36
  • CBAT $0.88
  • Analyst Decision
  • IVVD Strong Buy
  • CBAT
  • Analyst Count
  • IVVD 4
  • CBAT 0
  • Target Price
  • IVVD $7.89
  • CBAT N/A
  • AVG Volume (30 Days)
  • IVVD 38.6M
  • CBAT 204.2K
  • Earning Date
  • IVVD 03-27-2025
  • CBAT 03-14-2025
  • Dividend Yield
  • IVVD N/A
  • CBAT N/A
  • EPS Growth
  • IVVD N/A
  • CBAT N/A
  • EPS
  • IVVD N/A
  • CBAT 0.12
  • Revenue
  • IVVD $11,564,000.00
  • CBAT $207,423,403.00
  • Revenue This Year
  • IVVD N/A
  • CBAT $0.46
  • Revenue Next Year
  • IVVD $599.08
  • CBAT $13.78
  • P/E Ratio
  • IVVD N/A
  • CBAT $7.28
  • Revenue Growth
  • IVVD N/A
  • CBAT 2.32
  • 52 Week Low
  • IVVD $0.36
  • CBAT $0.77
  • 52 Week High
  • IVVD $4.74
  • CBAT $2.08
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 57.51
  • CBAT 50.45
  • Support Level
  • IVVD $1.33
  • CBAT $0.85
  • Resistance Level
  • IVVD $1.62
  • CBAT $0.94
  • Average True Range (ATR)
  • IVVD 0.44
  • CBAT 0.04
  • MACD
  • IVVD 0.01
  • CBAT 0.00
  • Stochastic Oscillator
  • IVVD 44.26
  • CBAT 60.00

Stock Price Comparison Chart: IVVD vs CBAT

IVVD
CBAT
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025051015202530354045505560IVVD VS CBAT

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization and distribution of a variety of standard and customized lithium-ion high-power rechargeable batteries. The company operates in two operating segments: CBAK's segment mainly includes the manufacture, commercialization and distribution of a wide variety of standard and customized lithium ion rechargeable batteries for use in a wide array of applications. Hitrans' segment mainly includes the development and manufacturing of NCM precursor and cathode materials. Geographically, it generates a majority of its revenue from Mainland China and also has an operation in Europe, the United States, Korea, and Other Countries.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use